1.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCGILL-T93-0176, NCI-T93-0176O, T93-0176
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: FCCC-95126, NCI-T95-0008D, T95-0008
|
|
3.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: No greater than 21 at diagnosis
Sponsor: NCI
Protocol IDs: CHLA-95-083, NCI-T95-0092O, NCT00002730, T95-0092
|
|
4.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: NCI
Protocol IDs: CAN-OCI-97-01-AML01, NCI-T96-0107, T96-0107
|
|
5.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-89HO204, NCI-T89-0124C, T89-0124
|
|
6.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: FCCC-88035, NCI-T88-0242D, T88-0242
|
|
7.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: at least 18
Sponsor: NCI
Protocol IDs: WCCC-CO-8897, NCI-T88-0189C, T88-0189
|
|
8.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-6000, NCI-T90-0175C, T90-0175
|
|
9.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MCGILL-ET-9014, NCI-T90-0198O, T90-0198
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9296, NCI-T92-0206D, T92-0206
|
|
11.
|
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-PRO00001793, Pro00001793, NCT00661336
|
Mobile | Español
